About Me
- Director, Cardiac Arrhythmia Service
- The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology
Click here to see Dr. Reddy's video on Atrial Fibrillation.
Vivek Y. Reddy, MD is Director of Cardiac Arrhythmia Services for The Mount Sinai Hospital and the Mount Sinai Health System, and The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology at Icahn School of Medicine at Mount Sinai.
Dr. Reddy is one of the nation’s premier cardiac electrophysiologists, leading a team of physician-scientists who are developing and testing advanced therapies for cardiac arrhythmias – including atrial fibrillation and ventricular tachycardias, the most common cause of sudden cardiac death. His team offers the full spectrum of arrhythmia therapies.
Dr. Reddy’s pioneering clinical research is changing the way cardiac patients are treated and cured. Under his leadership, Mount Sinai is the lead investigator on several multinational clinical trials exploring new arrhythmia procedures and technologies.
In addition, in 2014 Dr. Reddy implanted inside a patient's heart the world’s first miniature leadless pacemaker in the United States at The Mount Sinai Hospital.
The state of Florida requires out-of-state professionals who are registered to provide telehealth services to display a hyperlink to the Florida Department of Health telehealth web page. This allows Florida patients who are receiving medical care by telehealth to confirm the provider’s licensure and Florida registration.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
- Director, Cardiac Arrhythmia Service
- The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology
Click here to see Dr. Reddy's video on Atrial Fibrillation.
Vivek Y. Reddy, MD is Director of Cardiac Arrhythmia Services for The Mount Sinai Hospital and the Mount Sinai Health System, and The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology at Icahn School of Medicine at Mount Sinai.
Dr. Reddy is one of the nation’s premier cardiac electrophysiologists, leading a team of physician-scientists who are developing and testing advanced therapies for cardiac arrhythmias – including atrial fibrillation and ventricular tachycardias, the most common cause of sudden cardiac death. His team offers the full spectrum of arrhythmia therapies.
Dr. Reddy’s pioneering clinical research is changing the way cardiac patients are treated and cured. Under his leadership, Mount Sinai is the lead investigator on several multinational clinical trials exploring new arrhythmia procedures and technologies.
In addition, in 2014 Dr. Reddy implanted inside a patient's heart the world’s first miniature leadless pacemaker in the United States at The Mount Sinai Hospital.
The state of Florida requires out-of-state professionals who are registered to provide telehealth services to display a hyperlink to the Florida Department of Health telehealth web page. This allows Florida patients who are receiving medical care by telehealth to confirm the provider’s licensure and Florida registration.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Clinical Focus
- Atrial Fibrillation
- Atrial Flutter
- Cardiomyopathy
- Cardioversion
- Electrophysiology Study
- Renovascular Hypertension
- Stroke
- Tachycardia
- Ventricular Fibrillation
Show More
Education
MD, umims
Residency, Internal Medicine
Yale New Haven Hospital
Fellowship, Cardiovascular Disease
UChicago Medicine
Certifications
American Board of Internal Medicine
Awards
2009
The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology
2009
Endowed Professorship: The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology
2007
Best Doctors in Boston
2000
CIMIT Fellowship
Center for Minimally Invasive Therapy
1992
Howard Hughes Medical Institute Scholarship
1989
Alpha Omega Alpha Medical Society
Research
AF is the most common heart arrhythmia. Medications are only modestly effective, so we are working on catheter-based approaches to treat AF by directly cauterizing the tissue causing the problem. We are working with other approaches to do this catheter ablation procedure using laser energy or cryo energy (freezing tissue).
Left Atrial Appendage Closure
People with AF are at high risk for stroke-thus most people receive Warfarin Rx. We are working on approaches to use catheters to close the left atrial appendage. Then, patients would be protected from stroke without having to take Warfarin (Coumadin).
Catheter Ablation of Ventricular Tachycardia (VT)
Ventricular tachycardias are the most common cause of sudden death. The standard approach is to place defibrillators (ICDs) in patients at high risk for sudden death. We are working on approaches to use catheters to cauterize (ablate) the tissue responsible for these arrhythmias.
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Cardiovascular Medicine AssociatesGuggenheim Pavilion, 1190 Fifth Avenue - 1 South, New York, NY, 10029
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
Care Provider’s Concern
Likelihood to Recommend Care Provider
Good
Outstanding attention and care
Excellent and pleasant visit
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Reddy during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Boston Scientific Corporation
- Sirona Medical, Inc.
- BIOTRONIK
- W. L. Gore & Associates, Inc.
- Medtronic, Inc.
- BioTel Heart
- CardioNXT / AFTx
- Pulse Biosciences
- Novartis Pharmaceutical Corporation
- Abbott Inc.
- Adagio Medical
- Coremap Medical
- Cardiofocus Inc
- AtriAN
- Biostar Ventures
- Philips
- Novo Nordisk, Inc.
- Biosense Webster
- Append Medical
- Impulse Dynamics
- Cairdac
- Conformal, Inc
- FIRE1 Inc.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- SoundCath
- Anumana
- Manual Surgical Sciences
- CardiaCare
- Corisma
- LuxMed, Inc.
- Vizaramed
- DRS Vascular
- Laminar Medical
- Autonomix Inc.
- HRT
- Axon Therapeutics, Inc.
- Restore Medical
- Intershunt
- Ablacon Inc.
- Atraverse
- EP Frontiers
- Oracle Health
- East End Medical Inc.
- Newpace
- Biostar Ventures
- Focused Therapeutics
- Acutus Medical, Inc.
- Javelin, Inc.
- Aquaheart Inc.
- Atacor Inc.
- Nyra Medical
- Neutrace
- CardioNXT / AFTx
- Pulse Biosciences
- Backbeat Inc.
- Medlumics Inc.
- Cardiofocus Inc
- Surecor
- Circa Scientific, LLC
- Kardium
- APN Health
- BioSig Technologies, Inc.
- Corvia Medical Inc.
- Field Medical
- Dinova-Hangzhou Nuomao Medtech Co, Ltd
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Reddy during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Boston Scientific Corporation
- Sirona Medical, Inc.
- BIOTRONIK
- W. L. Gore & Associates, Inc.
- Medtronic, Inc.
- BioTel Heart
- CardioNXT / AFTx
- Pulse Biosciences
- Novartis Pharmaceutical Corporation
- Abbott Inc.
- Adagio Medical
- Coremap Medical
- Cardiofocus Inc
- AtriAN
- Biostar Ventures
- Philips
- Novo Nordisk, Inc.
- Biosense Webster
- Append Medical
- Impulse Dynamics
- Cairdac
- Conformal, Inc
- FIRE1 Inc.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- SoundCath
- Anumana
- Manual Surgical Sciences
- CardiaCare
- Corisma
- LuxMed, Inc.
- Vizaramed
- DRS Vascular
- Laminar Medical
- Autonomix Inc.
- HRT
- Axon Therapeutics, Inc.
- Restore Medical
- Intershunt
- Ablacon Inc.
- Atraverse
- EP Frontiers
- Oracle Health
- East End Medical Inc.
- Newpace
- Biostar Ventures
- Focused Therapeutics
- Acutus Medical, Inc.
- Javelin, Inc.
- Aquaheart Inc.
- Atacor Inc.
- Nyra Medical
- Neutrace
- CardioNXT / AFTx
- Pulse Biosciences
- Backbeat Inc.
- Medlumics Inc.
- Cardiofocus Inc
- Surecor
- Circa Scientific, LLC
- Kardium
- APN Health
- BioSig Technologies, Inc.
- Corvia Medical Inc.
- Field Medical
- Dinova-Hangzhou Nuomao Medtech Co, Ltd
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.